u/HedgeBullish

Reddit r/biotech_stocks
· tracked since Jan 2026
Calls
1
Win Rate
100.0%
return
+226.9%
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Win Rate 100% Long 1 Short 0
Win Rate
7d 100%
30d 0%
90d 0%
Average Return +226.9% Long Return +226.9% Short Return -
Average Return
7d +9.5%
30d -28.7%
90d -13.1%
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 06
$3.90
+226.9%
AbCellera's 2026 revenue and partnership inflection makes risk/reward compelling.
The author argues AbCellera is a buy at current levels because 2026 has multiple upside triggers: new AI-driven discovery partnerships, milestone and royalty revenue inflection, and clinical progress from partnered programs. Improving biotech sentiment further supports the risk/reward, which the author sees as increasingly compelling.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions

u/HedgeBullish has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: ABCL.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology